Semaglutide is a GLP-1 agonist (glucagon-like peptide-1) that mimics the body’s own hormones to affect appetite, satiety and blood sugar regulation. The substance was first developed for the treatment of type 2 diabetes, but has subsequently been shown to have a very good effect on weight loss and metabolic balance.
Semaglutide works by slowing down gastric emptying and suppressing the feeling of hunger, which facilitates more balanced and healthy eating. At the same time, it contributes to more stable blood sugar control by supporting insulin release in a demand-controlled manner.